Edgar Haber - Publications

Affiliations: 
1964-1988 Harvard Medical School, Boston, MA, United States 
Area:
Immunochemistry
Website:
https://www.geni.com/people/EDGAR-HABER/6000000031898901839

130 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1997 Bode C, Hanson SR, Schmedtje JF, Haber E, Mehwald P, Kelly AB, Harker LA, Runge MS. Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. Circulation. 95: 800-4. PMID 9054733 DOI: 10.1161/01.Cir.95.4.800  0.305
1996 George A, Huston JS, Haber E. Exploring and exploiting the antibody and Ig superfamily combining sites. Nature Biotechnology. 14: 584. PMID 9630946 DOI: 10.1038/Nbt0596-584  0.348
1996 Huston JS, Haber E. An overview of the 1996 Keystone meeting. Exploring and exploiting antibody and Ig superfamily combining sites. Immunotechnology : An International Journal of Immunological Engineering. 2: 253-60. PMID 9373307 DOI: 10.1016/S1380-2933(96)00052-8  0.349
1996 Huston JS, Margolies MN, Haber E. Antibody binding sites. Advances in Protein Chemistry. 49: 329-450. PMID 8908302 DOI: 10.1016/S0065-3233(08)60493-3  0.38
1996 Runge MS, Harker LA, Bode C, Ruef J, Kelly AB, Marzec UM, Allen E, Caban R, Shaw SY, Haber E, Hanson SR. Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation. 94: 1412-22. PMID 8823001 DOI: 10.1161/01.Cir.94.6.1412  0.331
1994 Schildbach JF, Shaw SY, Bruccoleri RE, Haber E, Herzenberg LA, Jager GC, Jeffrey PD, Panka DJ, Parks DR, Near RI. Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody. Protein Science : a Publication of the Protein Society. 3: 737-49. PMID 8061604 DOI: 10.1002/Pro.5560030503  0.382
1993 Schillbach JF, Near RI, Bruccoleri RE, Haber E, Jeffrey PD, Novotny J, Sheriff S, Margolies MN. Modulation of antibody affinity by a non-contact residue. Protein Science : a Publication of the Protein Society. 2: 206-14. PMID 8443598 DOI: 10.1002/Pro.5560020209  0.37
1993 Jeffrey PD, Strong RK, Sieker LC, Chang CY, Campbell RL, Petsko GA, Haber E, Margolies MN, Sheriff S. 26-10 Fab-digoxin complex: affinity and specificity due to surface complementarity. Proceedings of the National Academy of Sciences of the United States of America. 90: 10310-4. PMID 8234291 DOI: 10.1073/Pnas.90.21.10310  0.375
1992 Isobe M, Narula J, Southern JF, Strauss HW, Khaw BA, Haber E. Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction. Circulation. 85: 738-46. PMID 1735166 DOI: 10.1161/01.Cir.85.2.738  0.31
1992 Anthony J, Near R, Wong SL, Iida E, Ernst E, Wittekind M, Haber E, Ng SC. Production of stable anti-digoxin Fv in Escherichia coli. Molecular Immunology. 29: 1237-47. PMID 1528194 DOI: 10.1016/0161-5890(92)90060-B  0.306
1992 Bode C, Runge MS, Haber E. Purifying antibody-plasminogen activator conjugates. Bioconjugate Chemistry. 3: 269-72. PMID 1390979 DOI: 10.1021/Bc00016A001  0.372
1992 Chen F, Haber E, Matsueda GR. Availability of the B beta(15-21) epitope on cross-linked human fibrin and its plasmic degradation products. Thrombosis and Haemostasis. 67: 335-40. PMID 1379385 DOI: 10.1055/S-0038-1648443  0.374
1992 Haber E, Bode C, Matsueda GR, Reed GL, Runge MS. Antibody targeting as a thrombolytic strategy. Annals of the New York Academy of Sciences. 667: 365-81. PMID 1309057 DOI: 10.1111/J.1749-6632.1992.Tb51637.X  0.326
1992 Haber E. Engineered antibodies as pharmacological tools. Immunological Reviews. 130: 189-212. PMID 1286870 DOI: 10.1111/J.1600-065X.1992.Tb01526.X  0.388
1991 Huston JS, Mudgett-Hunter M, Tai MS, McCartney J, Warren F, Haber E, Oppermann H. Protein engineering of single-chain Fv analogs and fusion proteins. Methods in Enzymology. 203: 46-88. PMID 1762568 DOI: 10.1016/0076-6879(91)03005-2  0.332
1991 Lukacova D, Matsueda GR, Haber E, Reed GL. Inhibition of factor XIII activation by an anti-peptide monoclonal antibody. Biochemistry. 30: 10164-70. PMID 1681898 DOI: 10.1021/Bi00106A013  0.381
1990 Tai MS, Mudgett-Hunter M, Levinson D, Wu GM, Haber E, Oppermann H, Huston JS. A bifunctional fusion protein containing Fc-binding fragment B of staphylococcal protein A amino terminal to antidigoxin single-chain Fv. Biochemistry. 29: 8024-30. PMID 2261460 DOI: 10.1021/Bi00487A005  0.324
1990 Runge MS, Bode C, Savard CE, Matsueda GR, Haber E. Antibody-directed fibrinolysis: a bispecific (Fab')2 that binds to fibrin and tissue plasminogen activator. Bioconjugate Chemistry. 1: 274-7. PMID 2129015 DOI: 10.1021/Bc00004A008  0.376
1990 Branscomb EE, Runge MS, Savard CE, Adams KM, Matsueda GR, Haber E. Bispecific monoclonal antibodies produced by somatic cell fusion increase the potency of tissue plasminogen activator. Thrombosis and Haemostasis. 64: 260-6. PMID 2125375 DOI: 10.1055/S-0038-1647297  0.33
1990 Near RI, Ng SC, Mudgett-Hunter M, Hudson NW, Margolies MN, Seidman JG, Haber E, Jacobson MA. Heavy and light chain contributions to antigen binding in an anti-digoxin chain recombinant antibody produced by transfection of cloned anti-digoxin antibody genes. Molecular Immunology. 27: 901-9. PMID 2120577 DOI: 10.1016/0161-5890(90)90157-U  0.341
1990 Bode C, Runge MS, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E. Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator. Circulation. 81: 1974-80. PMID 2111744 DOI: 10.1161/01.Cir.81.6.1974  0.342
1990 Charpie JR, Runge MS, Matsueda GR, Haber E. A bispecific antibody enhances the fibrinolytic potency of single-chain urokinase. Biochemistry. 29: 6374-8. PMID 1698452 DOI: 10.1021/Bi00479A005  0.394
1989 Khaw BA, Torchilin VP, Klibanov AL, Nossiff ND, Powers JB, Strauss HW, Haber E. Modification of monoclonal antimyosin antibody: enhanced specificity of localization and scintigraphic visualization in acute experimental myocardial infarction. Journal of Molecular and Cellular Cardiology. 21: 31-5. PMID 2733028 DOI: 10.1016/0022-2828(89)90835-3  0.35
1989 Love TW, Runge MS, Haber E, Quertermous T. Recombinant antibodies possessing novel effector functions. Methods in Enzymology. 178: 515-27. PMID 2513468 DOI: 10.1016/0076-6879(89)78037-X  0.404
1989 Near RI, Haber E. Characterization of the heavy and light chain immunoglobulin variable region genes used in a set of anti-digoxin antibodies. Molecular Immunology. 26: 371-82. PMID 2497340 DOI: 10.1016/0161-5890(89)90126-0  0.328
1988 Bruccoleri RE, Haber E, Novotný J. Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature. 335: 564-8. PMID 3419534 DOI: 10.1038/335564A0  0.351
1988 Charpie JR, Haber E, Matsueda GR. A sequence-dependent monoclonal antibody specific for single-chain urokinase. Biochemical and Biophysical Research Communications. 152: 910-5. PMID 3365258 DOI: 10.1016/S0006-291X(88)80126-8  0.349
1988 Runge MS, Bode C, Matsueda GR, Haber E. Conjugation to an antifibrin monoclonal antibody enhances the fibrinolytic potency of tissue plasminogen activator in vitro. Biochemistry. 27: 1153-7. PMID 3130094 DOI: 10.1021/Bi00404A012  0.362
1988 Panka DJ, Mudgett-Hunter M, Parks DR, Peterson LL, Herzenberg LA, Haber E, Margolies MN. Variable region framework differences result in decreased or increased affinity of variant anti-digoxin antibodies. Proceedings of the National Academy of Sciences of the United States of America. 85: 3080-4. PMID 3129726 DOI: 10.1073/Pnas.85.9.3080  0.343
1988 Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotný J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 85: 5879-83. PMID 3045807 DOI: 10.1073/Pnas.85.16.5879  0.368
1987 Bode C, Runge MS, Newell JB, Matsueda GR, Haber E. Thrombolysis by a fibrin-specific antibody Fab'-urokinase conjugate. Journal of Molecular and Cellular Cardiology. 19: 335-41. PMID 3612817 DOI: 10.1016/S0022-2828(87)80578-3  0.405
1987 Liau CS, Haber E, Matsueda GR. Evaluation of monoclonal antifibrin antibodies by their binding to human blood clots. Thrombosis and Haemostasis. 57: 49-54. PMID 3590080 DOI: 10.1055/S-0038-1651060  0.395
1987 Runge MS, Bode C, Matsueda GR, Haber E. Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo. Proceedings of the National Academy of Sciences of the United States of America. 84: 7659-62. PMID 3118374 DOI: 10.1073/Pnas.84.21.7659  0.379
1987 Schnee JM, Runge MS, Matsueda GR, Hudson NW, Seidman JG, Haber E, Quertermous T. Construction and expression of a recombinant antibody-targeted plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America. 84: 6904-8. PMID 3116546 DOI: 10.1073/Pnas.84.19.6904  0.345
1987 Torchilin VP, Klibanov AL, Nossiff ND, Slinkin MA, Strauss HW, Haber E, Smirnov VN, Khaw BA. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding. Hybridoma. 6: 229-40. PMID 3110049 DOI: 10.1089/Hyb.1987.6.229  0.36
1987 Novotny J, Bruccoleri RE, Carlson WD, Handschumacher M, Haber E. Antigenicity of myohemerythrin. Science (New York, N.Y.). 238: 1584-6. PMID 2446393 DOI: 10.1126/Science.2446393  0.304
1986 Torchilin VP, Khaw BA, Klibanov AL, Slinkin MA, Haber E. [Modification of monoclonal antibodies by polymers possessing chelating properties]. Biulleten' Eksperimental'Noä­ Biologii I Meditsiny. 102: 63-5. PMID 3730595 DOI: 10.1007/Bf00840001  0.347
1986 Dzau VJ, Mudgett-Hunter M, Haber E. Monoclonal antibodies as molecular probes to study structural heterogeneity between human and animal renins and other aspartyl proteinases. The Journal of Clinical Endocrinology and Metabolism. 62: 424-8. PMID 3510227 DOI: 10.1210/Jcem-62-2-424  0.38
1986 Novotný J, Haber E. Static accessibility model of protein antigenicity: the case of scorpion neurotoxin. Biochemistry. 25: 6748-54. PMID 2432922 DOI: 10.1021/Bi00370A004  0.306
1986 Novotný J, Handschumacher M, Haber E. Location of antigenic epitopes on antibody molecules. Journal of Molecular Biology. 189: 715-21. PMID 2431154 DOI: 10.1016/0022-2836(86)90502-4  0.363
1986 Day RP, Hui KY, Gure M, Carlson WD, Dzau VJ, Haber E. A monoclonal antibody specific for the amino terminal sequence of human prorenin identifies a common epitope on renal and amniotic fluid inactive renins. Journal of Hypertension. 4: 375-81. PMID 2426349 DOI: 10.1097/00004872-198606000-00020  0.401
1986 Evin G, Carlson WD, Handschumacher M, Novotný J, Matsueda GR, Haber E, Bouhnik J, Galen FX, Ménard J, Corvol P. Study of the antigenic determinants of human renin. Hypertension. 8: II72-7. PMID 2424834 DOI: 10.1161/01.Hyp.8.6_Pt_2.Ii72  0.353
1986 Novotný J, Handschumacher M, Haber E, Bruccoleri RE, Carlson WB, Fanning DW, Smith JA, Rose GD. Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proceedings of the National Academy of Sciences of the United States of America. 83: 226-30. PMID 2417241 DOI: 10.1073/Pnas.83.2.226  0.322
1985 Hui KY, Haber E, Matsueda GR. Immunodetection of human fibrin using monoclonal antibody-64C5 in an extracorporeal chicken model. Thrombosis and Haemostasis. 54: 524-7. PMID 4082089 DOI: 10.1055/S-0038-1657889  0.352
1985 Mudgett-Hunter M, Anderson W, Haber E, Margolies MN. Binding and structural diversity among high-affinity monoclonal anti-digoxin antibodies. Molecular Immunology. 22: 477-88. PMID 4033667 DOI: 10.1016/0161-5890(85)90132-4  0.414
1985 Bode C, Matsueda GR, Hui KY, Haber E. Antibody-directed urokinase: a specific fibrinolytic agent. Science (New York, N.Y.). 229: 765-7. PMID 4023710 DOI: 10.1126/Science.4023710  0.414
1985 Leikin J, Vogel S, Graff J, Goldman-Leikin R, Butler VP, Haber E, Smith TW. Use of fab fragments of digoxin-specific antibodies in the therapy of massive digoxin poisoning. Annals of Emergency Medicine. 14: 175-8. PMID 3970406 DOI: 10.1016/S0196-0644(85)81085-4  0.327
1985 Haber E. Defining the physiologic and pathophysiologic roles of renin: the role of specific inhibitors. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 5: A14-22. PMID 3887901 DOI: 10.1016/S0272-6386(85)80060-3  0.328
1985 Carlson W, Karplus M, Haber E. Construction of a model for the three-dimensional structure of human renal renin. Hypertension. 7: 13-26. PMID 3884498 DOI: 10.1161/01.Hyp.7.1.13  0.335
1985 Babbitt BP, Allen PM, Matsueda G, Haber E, Unanue ER. Binding of immunogenic peptides to Ia histocompatibility molecules. Nature. 317: 359-61. PMID 3876513 DOI: 10.1038/317359A0  0.323
1985 Haber E. Quantifying cell death in the myocardium: myosin specific antibody in the evaluation of membrane defects. Journal of Molecular and Cellular Cardiology. 17: 53-8. PMID 2993633 DOI: 10.1016/0022-2828(85)90008-2  0.339
1985 Nussberger J, Matsueda G, Re RN, Haber E. Recognition of peptide orientation: studies with angiotensin II in the guinea-pig. Molecular Immunology. 22: 619-21. PMID 2410776 DOI: 10.1016/0161-5890(85)90090-2  0.314
1984 Nussberger J, Mudgett-Hunter M, Matsueda G, Haber E. A monoclonal antibody specific for the carboxy-terminus of angiotensin II. Hybridoma. 3: 373-6. PMID 6526402 DOI: 10.1089/Hyb.1984.3.373  0.344
1984 Khaw BA, Mattis JA, Melincoff G, Strauss HW, Gold HK, Haber E. Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction. Hybridoma. 3: 11-23. PMID 6469268 DOI: 10.1089/Hyb.1984.3.11  0.339
1984 Dzau VJ, Kopelman RI, Barger AC, Haber E. Comparison of renin-specific IgG and antibody fragments in studies of blood pressure regulation. The American Journal of Physiology. 246: H404-9. PMID 6367489 DOI: 10.1152/Ajpheart.1984.246.3.H404  0.339
1984 Haber E. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does? Journal of Hypertension. 2: 223-30. PMID 6099385 DOI: 10.1097/00004872-198406000-00002  0.318
1983 Hui KY, Haber E, Matsueda GR. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science (New York, N.Y.). 222: 1129-32. PMID 6648524 DOI: 10.1126/Science.6648524  0.401
1983 Haber E, Zusman R, Burton J, Dzau VJ, Barger AC. Is renin a factor in the etiology of essential hypertension? Hypertension. 5: V8-15. PMID 6418650 DOI: 10.1161/01.Hyp.5.6_Pt_3.V8  0.359
1983 Dzau VJ, Devine D, Mudgett-Hunter M, Kopelman RI, Barger AC, Haber E. Antibodies as specific renin inhibitors: studies with polyclonal and monoclonal antibodies and Fab fragments. Clinical and Experimental Hypertension. Part a, Theory and Practice. 5: 1207-20. PMID 6357564 DOI: 10.3109/10641968309048852  0.395
1983 Haber E. Inhibitors of renin: present and future. Clinical and Experimental Hypertension. Part a, Theory and Practice. 5: 1193-205. PMID 6357563 DOI: 10.3109/10641968309048851  0.35
1983 Pacella BL, Hui KY, Haber E, Matsueda GR. Induction of fibrin-specific antibodies by immunization with synthetic peptides that correspond to amino termini of thrombin cleavage sites. Molecular Immunology. 20: 521-7. PMID 6348513 DOI: 10.1016/0161-5890(83)90090-1  0.371
1983 Mudgett-Hunter M, Budzik GP, Donahoe PK, Khaw BA, Margolies MN, Ridgeway EC, Haber E. Monoclonal antibodies as physiologic probes. Basic Life Sciences. 25: 101-28. PMID 6190474 DOI: 10.1007/978-1-4684-4460-5_8  0.34
1983 Marciniak RA, Wands JR, Bruns RR, Malchesky PS, Nose Y, Haber E. Quantitative removal of hepatitis B viral antigens from serum by a monoclonal IgM coupled to a biocompatible solid-phase support. Proceedings of the National Academy of Sciences of the United States of America. 80: 3821-5. PMID 6190181 DOI: 10.1073/Pnas.80.12.3821  0.339
1983 Khaw BA, Torchilin VP, Berdichevskii VR, Barsukov AA, Klibanov AL, Smirnov VN, Haber E. Enhancing specificity and stability of targeted liposomes by coincorporation of sialoglycoprotein and antibody on liposomes Bulletin of Experimental Biology and Medicine. 95: 776-781. DOI: 10.1007/Bf00834903  0.336
1982 Dzau VJ, Brenner A, Wolfsohn S, Haber E. Characterization of antibodies to canine renal renin. Studies of interspecies homology of renin using antibodies as probe. Hypertension. 4: 341-7. PMID 7040231 DOI: 10.1161/01.Hyp.4.3.341  0.406
1982 Re R, Fallon JT, Dzau V, Ouay SC, Haber E. Renin synthesis by canine aortic smooth muscle cells in culture. Life Sciences. 30: 99-106. PMID 7033709 DOI: 10.1016/0024-3205(82)90641-5  0.319
1982 Homcy CJ, Rockson SG, Haber E. An antiidiotypic antibody that recognizes the beta-adrenergic receptor. The Journal of Clinical Investigation. 69: 1147-54. PMID 6279698 DOI: 10.1172/Jci110550  0.346
1982 Haber E, Katus HA, Hurrell JG, Matsueda GR, Ehrlich P, Zurawski VR, Khaw BA. Detection and quantification of myocardial cell death: application of monoclonal antibodies specific for cardiac myosin. Journal of Molecular and Cellular Cardiology. 14: 139-46. PMID 6183437 DOI: 10.1016/0022-2828(82)90142-0  0.361
1982 Katus HA, Hurrell JG, Matsueda GR, Ehrlich P, Zurawski VR, Khaw BA, Haber E. Increased specificity in human cardiac-myosin radioimmunoassay utilizing two monoclonal antibodies in a double sandwich assay. Molecular Immunology. 19: 451-5. PMID 6178967 DOI: 10.1016/0161-5890(82)90211-5  0.38
1982 Haber E. Antibodies in Vivo Pharmacological Reviews. 34: 77-84. DOI: 10.1007/978-1-4684-4964-8_28  0.368
1981 Dzau V, Mudgett-Hunter M, Kapler G, Haber E. Monoclonal antibodies binding renal renin. Hypertension. 3: II-4-8. PMID 6795117 DOI: 10.1161/01.Hyp.3.6_Pt_2.Ii-4  0.389
1981 Hurrell JG, Katus HA, Khaw BA, Haber E, Zurawski VR. Monoclonal antibodies directed against human myoglobin: characterization and application in a bideterminant radioimmunoassay. Journal of Immunological Methods. 45: 249-54. PMID 6169768 DOI: 10.1016/0022-1759(81)90303-3  0.358
1980 Dzau VJ, Brenner A, Emmett N, Haber E. Identification of renin and renin-like enzymes in rat brain by a renin-specific antibody. Clinical Science (London, England : 1979). 59: 45s-47s. PMID 7004734 DOI: 10.1042/Cs059045S  0.346
1980 Rockson SG, Homcy CJ, Haber E. Anti-alprenolol antibodies in the rabbit. A new probe for the study of beta-adrenergic receptor interaction. Circulation Research. 46: 808-13. PMID 6247081 DOI: 10.1161/01.Res.46.6.808  0.329
1980 Ehrlich PH, Matsueda GR, Margolies MN, Husain SS, Haber E. Isolation of an active heavy-chain variable domain from a homogeneous rabbit antibody by cathepsin B digestion of the aminoethylated heavy chain. Biochemistry. 19: 4091-6. PMID 6157405 DOI: 10.1021/Bi00558A029  0.392
1979 Khaw BA, Fallon JT, Beller GA, Haber E. Specificity of localization of myosin-specific antibody fragments in experimental myocardial infarction. Histologic, histochemical, autoradiographic and scintigraphic studies. Circulation. 60: 1527-31. PMID 498480 DOI: 10.1161/01.Cir.60.7.1527  0.339
1979 Torchilin VP, Khaw BA, Smirnov VN, Haber E. Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochemical and Biophysical Research Communications. 89: 1114-9. PMID 496941 DOI: 10.1016/0006-291X(79)92123-5  0.362
1979 Slater EE, Gounaris AD, Haber E. Isolation of a renal thiol protease that activates inactive plasma renin. Clinical Science (London, England : 1979). 57: 93s-96s. PMID 396096 DOI: 10.1042/Cs057093S  0.302
1979 Ehrlich PH, Matsueda GR, Haber E, Margolies MN. Isolation and characterization of an active variable domain from a homogeneous rabbit antibody light chain. Biochemistry. 18: 4411-8. PMID 114216 DOI: 10.1021/Bi00587A022  0.352
1978 Khaw BA, Gold HK, Leinbach RC, Fallon JT, Strauss W, Pohost GM, Haber E. Early imaging of experimental myocardial infarction by intracoronary administraion of 131I-labelled anticardiac myosin (Fab')2 fragments. Circulation. 58: 1137-42. PMID 709769 DOI: 10.1161/01.Cir.58.6.1137  0.32
1978 Khaw BA, Gold HK, Fallon JT, Haber E. Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains. Circulation. 58: 1130-6. PMID 709768 DOI: 10.1161/01.Cir.58.6.1130  0.308
1978 Slater EE, Haber E. A large form of renin from normal human kidney. The Journal of Clinical Endocrinology and Metabolism. 47: 105-9. PMID 400710 DOI: 10.1210/Jcem-47-1-105  0.328
1978 Homcy C, Wrenn S, Haber E. Affinity purification of cardiac adenylate cyclase: dependence on prior hydrophobic resolution. Proceedings of the National Academy of Sciences of the United States of America. 75: 59-63. PMID 272673 DOI: 10.1073/Pnas.75.1.59  0.303
1978 Zurawski VR, Haber E, Black PH. Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines. Science (New York, N.Y.). 199: 1439-41. PMID 204013 DOI: 10.1126/Science.204013  0.338
1978 Rosemblatt MS, Haber E. Isolation of an active variable-domain fragment from a homogeneous rabbit antibody heavy chain. Physiochemical and immunological properties. Biochemistry. 17: 3877-82. PMID 100137 DOI: 10.1021/Bi00611A031  0.353
1978 Cannon LE, Margolies MN, Haber E. Light chain variable region sequence of rabbit antipneumococcal type III polysaccharide antibody 3368. Biochemistry. 17: 3101-9. PMID 100133 DOI: 10.1021/Bi00608A025  0.326
1978 Ehrlich PH, Matsueda GR, Margolies MN, Haber E. Preparation of an active Fd fragment by cyanogen bromide cleavage of an IgG heavy chain from a homogeneous rabbit antibody. Immunochemistry. 15: 937-40. PMID 35462 DOI: 10.1016/0161-5890(78)90127-X  0.356
1977 Poulsen K, Haber E, Burton J. On the specificity of human renin. Studies with peptide inhibitors. Biochimica Et Biophysica Acta. 452: 533-7. PMID 1009126 DOI: 10.1016/0005-2744(76)90205-9  0.3
1977 Butler VP, Schmidt DH, Smith TW, Haber E, Raynor BD, Demartini P. Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs. The Journal of Clinical Investigation. 59: 345-59. PMID 299860 DOI: 10.1172/Jci108647  0.375
1976 Khaw BA, Beller GA, Haber E, Smith TW. Localization of cardiac myosin-specific antibody in myocardial infarction. Journal of Clinical Investigation. 58: 439-446. PMID 956377 DOI: 10.1172/Jci108488  0.317
1976 Smith TW, Haber E, Yeatman L, Butler VP. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. The New England Journal of Medicine. 294: 797-800. PMID 943040 DOI: 10.1056/Nejm197604082941501  0.342
1975 Brauer AW, Margolies MN, Haber E. The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides. Biochemistry. 14: 3029-35. PMID 1148190 DOI: 10.1021/Bi00684A036  0.3
1975 Margolies MN, Cannon LE, Strosberg AD, Haber E. Diversity of light chain variable region sequences among rabbit antibodies elicited by the same antigens. Proceedings of the National Academy of Sciences of the United States of America. 72: 2180-4. PMID 1094456 DOI: 10.1073/Pnas.72.6.2180  0.343
1974 Poulsen K, Sancho J, Haber E. A simplified radioimmunoassay for plasma aldosterone employing an antibody of unique specificity. Clinical Immunology and Immunopathology. 2: 373-80. PMID 4857015 DOI: 10.1016/0090-1229(74)90055-5  0.306
1974 Strosberg AD, Collins JJ, Black PH, Malamud D, Wilbert S, Bloch KJ, Haber E. Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: demonstration of production of specific antibody to the immunizing antigen. Proceedings of the National Academy of Sciences of the United States of America. 71: 263-4. PMID 4150021 DOI: 10.1073/Pnas.71.2.263  0.343
1974 Vetter W, Freedlender E, Haber E. Specificity of antialdosterone antibodies in relation to the site of coupling Clinical Immunology and Immunopathology. 2: 361-372. PMID 4133190 DOI: 10.1016/0090-1229(74)90054-3  0.384
1973 Frangione B, Lee L, Haber E, Bloch KJ. Protein Hal: partial deletion of a " " immunoglobulin gene(s) and apparent reinitiation at an internal AUG codon. Proceedings of the National Academy of Sciences of the United States of America. 70: 1073-7. PMID 4577790 DOI: 10.1073/Pnas.70.4.1073  0.301
1973 Lefkowitz RJ, Sharp GW, Haber E. Specific binding of -adrenergic catecholamines to a subcellular fraction from cardiac muscle. The Journal of Biological Chemistry. 248: 342-9. PMID 4144255  0.349
1972 Curd J, Smith TW, Jaton JC, Haber E. The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin. Proceedings of the National Academy of Sciences of the United States of America. 68: 2401-6. PMID 5289875 DOI: 10.1073/Pnas.68.10.2401  0.378
1972 Lefkowitz RJ, Haber E, O'Hara D. Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography. Proceedings of the National Academy of Sciences of the United States of America. 69: 2828-32. PMID 4507606 DOI: 10.1073/Pnas.69.10.2828  0.452
1972 Poulsen K, Fraser KJ, Haber E. An active derivative of rabbit antibody light chain composed of the constant and the variable domains held together only by a native disulfide bond. Proceedings of the National Academy of Sciences of the United States of America. 69: 2495-9. PMID 4506770 DOI: 10.1073/Pnas.69.9.2495  0.348
1972 Haber E. Homogeneous elicited antibodies: induction, characterization, isolation, and structure. Annals of the New York Academy of Sciences. 190: 285-305. PMID 4400335 DOI: 10.1111/J.1749-6632.1971.Tb13542.X  0.334
1972 Strosberg AD, Fraser KJ, Margolies MN, Haber E. Amino acid sequence of rabbit pneumococcal antibody. I. Light-chain cysteine-containing peptides. Biochemistry. 11: 4978-85. PMID 4118103 DOI: 10.1021/Bi00776A017  0.33
1972 Meyers OL, Shoji M, Haber E, Remold HG, David JR. Cellular hypersensitivity: the production of antibody by cultures of lymphocytes producing macrophage inhibitory factor. Cellular Immunology. 3: 442-7. PMID 4111124 DOI: 10.1016/0008-8749(72)90249-3  0.324
1972 Vetter W, Freedlender E, Haber E. Production And Characterization Of Antibodies Elicited By Different Aldosterone-Protein Conjugates European Journal of Endocrinology. 68. DOI: 10.1530/Acta.0.069S032  0.341
1971 Africa B, Haber E. The production and characterization of specific antibodies to aldosterone. Immunochemistry. 8: 479-86. PMID 5556922 DOI: 10.1016/0019-2791(71)90399-5  0.346
1971 Waterfield MD, Corbett C, Haber E. A protein sequencing device of simple construction. Analytical Biochemistry. 38: 475-92. PMID 5493071 DOI: 10.1016/0003-2697(70)90473-2  0.499
1971 Lefkowitz RJ, Haber E. A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor. Proceedings of the National Academy of Sciences of the United States of America. 68: 1773-7. PMID 4399664 DOI: 10.1073/Pnas.68.8.1773  0.422
1971 Jaton JC, Waterfield MD, Margolies MN, Bloch KJ, Haber E. Variation in the primary structure of antibodies during the course of immunization. Biochemistry. 10: 1583-7. PMID 4103273 DOI: 10.1021/bi00785a012  0.482
1970 Waterfield M, Haber E. Amino acid sequence analysis with methyl isothiocyanate. Resolution of the methylthiohydantoins by gas-liquid partition chromatography. Biochemistry. 9: 832-9. PMID 5461406 DOI: 10.1021/Bi00806A016  0.474
1970 Jaton JC, Waterfield MD, Margolies MN, Haber E. Isolation and characterization of structurally homogeneous antibodies from antipneumococcal sera. Proceedings of the National Academy of Sciences of the United States of America. 66: 959-66. PMID 4393268 DOI: 10.1073/Pnas.66.3.959  0.588
1970 Smith TW, Butler VP, Haber E. Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. Biochemistry. 9: 331-337. PMID 4312850 DOI: 10.1021/Bi00804A020  0.374
1969 Fischer J, Spragg J, Talamo RC, Pierce JV, Suzuki K, Austen KF, Haber E. Structural requirements for binding of bradykinin to antibody. 3. The effect of carrier on antibody specificity. Biochemistry. 8: 3750-7. PMID 5820666 DOI: 10.1021/Bi00837A039  0.374
1969 Spragg J, Talamo RC, Suzuki K, Appelbaum DM, Austen KF, Haber E. Structural requirements for binding of bradykinin to antibody. II. Studies with bradykinin fragments. Biochemistry. 7: 4086-9. PMID 5749176 DOI: 10.1021/Bi00851A042  0.351
1969 Smith TW, Butler VP, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. The New England Journal of Medicine. 281: 1212-1216. PMID 5388455 DOI: 10.1056/Nejm196911272812203  0.301
1969 Haber E, Koerner T, Page LB, Kliman B, Purnode A. Application Of A Radioimmunoassay For Angiotensin I To The Physiologic Measurements Of Plasma Renin Activity In Normal Human Subjects. The Journal of Clinical Endocrinology and Metabolism. 29: 1349-1355. PMID 4311082 DOI: 10.1210/Jcem-29-10-1349  0.332
1969 Richards FF, Pincus JH, Bloch KJ, Barnes WT, Haber E. The relationship between antigenic complexity and heterogeneity in the antibody response. Biochemistry. 8: 1377-84. PMID 4185034 DOI: 10.1021/Bi00832A011  0.329
1968 Spragg J, Schröder E, Stewart JM, Austen KF, Haber E. Structural requirements for binding to antibody of sequence variants of bradykinin. Biochemistry. 6: 3933-41. PMID 5299782 DOI: 10.1021/Bi00864A040  0.34
1968 Pincus JH, Haber E, Katz M, Pappenheimer AM. Antibodies to pneumococcal polysaccharides: relation between binding and electrophoretic heterogeneity. Science (New York, N.Y.). 162: 667-8. PMID 4386872 DOI: 10.1126/Science.162.3854.667  0.364
1967 Cathou RE, Haber E. Structure of the antibody combining site. I. Hapten stabilization of antibody conformation. Biochemistry. 6: 513-8. PMID 6047635 DOI: 10.1021/Bi00854A020  0.353
1967 Richards FF, Haber E. Antibodies to relatively homogeneous haptens: the temporal pattern of their antigen-binding energies. Biochimica Et Biophysica Acta. 140: 558-60. PMID 4167485 DOI: 10.1016/0005-2795(67)90537-5  0.33
1967 Haber E, Stone M. Extensive degradation of antibody by pepsin. Biochemistry. 6: 1974-80. PMID 4167434 DOI: 10.1021/Bi00859A014  0.363
1966 Haber E, Page LB, Richards FF. Radio immunoassay employing gel filtration. Analytical Biochemistry. 12: 163-72. PMID 4285060 DOI: 10.1016/0003-2697(65)90155-7  0.365
1965 HABER E, PAGE LB, JACOBY GA. SYNTHESIS OF ANTIGENIC BRANCH-CHAIN COPOLYMERS OF ANGIOTENSIN AND Biochemistry. 4: 693-698. PMID 14323573 DOI: 10.1021/Bi00880A013  0.313
1964 HABER E. RECOVERY OF ANTIGENIC SPECIFICITY AFTER DENATURATION AND COMPLETE Proceedings of the National Academy of Sciences of the United States Of. 52: 1099-1106. PMID 14224389 DOI: 10.1073/Pnas.52.4.1099  0.316
1962 HABER E, BENNETT JC. Polarization of fluorescence as a measure of antigen-antibody interaction Proceedings of the National Academy of Sciences of the United States of America. 48: 1935-1942. PMID 13951630 DOI: 10.1073/Pnas.48.11.1935  0.302
1962 HABER E, ANFINSEN CB. Side-chain interactions governing the pairing of half-cystine residues in ribonuclease. The Journal of Biological Chemistry. 237: 1839-44. PMID 13903380  0.448
1961 HABER E, ANFINSEN CB. Regeneration of enzyme activity by air oxidation of reduced subtilisin-modified ribonuclease. The Journal of Biological Chemistry. 236: 422-4. PMID 13710229  0.43
1961 ANFINSEN CB, HABER E. Studies on the reduction and re-formation of protein disulfide bonds. The Journal of Biological Chemistry. 236: 1361-3. PMID 13683523  0.43
1961 ANFINSEN CB, HABER E, SELA M, WHITE FH. The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain. Proceedings of the National Academy of Sciences of the United States of America. 47: 1309-14. PMID 13683522 DOI: 10.1073/Pnas.47.9.1309  0.61
Show low-probability matches.